Atsushi Tanaka, Koutarou Nishimura, Wataru Saika, Ayana Kon, Yui Koike, Hiromi Tatsumi, June Takeda, Masaki Nomura, Weijia Zang, Manabu Nakayama, et al. SETBP1 is dispensable for normal and malignant hematopoiesis. Leukemia. 2023
Hideki Makishima, Ryunosuke Saiki, Yasuhito Nannya, Sophia Korotev, Carmelo Gurnari, June Takeda, Yukihide Momozawa, Steve Best, Pramila Krishnamurthy, Tetsuichi Yoshizato, et al. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Blood. 2023. 141. 5. 534-549
June Takeda, Kenichi Yoshida, Masahiro M Nakagawa, Yasuhito Nannya, Akinori Yoda, Ryunosuke Saiki, Yotaro Ochi, Lanying Zhao, Rurika Okuda, Xingxing Qi, et al. Amplified EPOR/JAK2 genes define a unique subtype of acute erythroid leukemia. Blood cancer discovery. 2022. 3. 5. 410-427
Keita Yamamoto, Susumu Goyama, Shuhei Asada, Takeshi Fujino, Taishi Yonezawa, Naru Sato, Reina Takeda, Akiho Tsuchiya, Tomofusa Fukuyama, Yosuke Tanaka, et al. A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells. Cell Reports. 2021. 36. 8. 109576-109576
Ayana Kon. Clonal evolution of myeloid malignancies. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2020. 61. 9. 1120-1129
骨髄異形成症候群におけるSRSF2変異とSTAG2変異と協調的関係(Cooperative effects of SRSF2 and STAG2 mutations on development of myelodysplastic syndrome and its related disorders)
(日本癌学会総会記事 2022)
単一細胞マルチオミクス解析によるクローン性造血の病態解明(Distinct pathogenesis of clonal hematopoiesis revealed by single-cell multi-omics sequencing)
(日本癌学会総会記事 2022)
Mis-splicing due to somatic U2AF2 mutations in myeloid neoplasms(和訳中)
(日本癌学会総会記事 2022)
骨髄系腫瘍におけるDDX41胚細胞変異・体細胞変異の分子病態の解明(Elucidating the mechanism of clonal evolution of DDX41 mutated cells in myeloid malignancies)
(日本癌学会総会記事 2022)
ETNK1 mutations defines a subclass of der(1;7)(q10;p10) in myelodysplastic syndromes(和訳中)
(日本血液学会学術集会 2021)